---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-21-017038"
form_type: "8-K"
ticker: "DMAC"
cik: "0001401040"
company_name: "DiaMedica Therapeutics Inc."
filed_at: "2021-07-16T23:59:59+00:00"
generated_at: "2026-06-30T04:47:04.764082+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# DiaMedica Therapeutics elects two new directors at 2021 AGM

## Summary
- Shareholders elected Amy Burroughs and Charles Semba, M.D. as directors effective immediately.
- Burroughs will serve on Audit and Nominating & Governance committees; Semba on Audit and Compensation committees.
- Four incumbent directors re-elected: Pilnik, Giuffre, Parsons, Pauls. All received >96% votes for.
- Baker Tilly US, LLP appointed as independent auditor for FY2021 with 10,734,645 votes for, none against.
- Quorum of 57.2% present; 10,748,667 shares voted out of 18,786,157 outstanding.

## SEC filing metadata
- accession: 0001437749-21-017038
- form_type: 8-K
- ticker: DMAC
- cik: 0001401040
- company_name: DiaMedica Therapeutics Inc.
- filed_at: 2021-07-16T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1401040/000143774921017038/0001437749-21-017038-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1401040/000143774921017038/dmtp20210715_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-21-017038
- JSON: https://secwatch.observer/filing/0001437749-21-017038.json
- Plain text: https://secwatch.observer/filing/0001437749-21-017038.txt

## Key facts
- Executive change
  Charles Semba, M.D. was elected as director at DiaMedica Therapeutics Inc..
  - Action: elected
  - Role: director
  source text: the Company’s shareholders elected each of Amy Burroughs and Charles Semba, M.D. as a director of the Company effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1401040/000143774921017038/0001437749-21-017038-index.htm
- Executive change
  Amy Burroughs was elected as director at DiaMedica Therapeutics Inc..
  - Action: elected
  - Role: director
  source text: the Company’s shareholders elected each of Amy Burroughs and Charles Semba, M.D. as a director of the Company effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1401040/000143774921017038/0001437749-21-017038-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.